Reece P A, Disney A P, Stafford I, Shastry J C
Br J Clin Pharmacol. 1985 Aug;20(2):159-62. doi: 10.1111/j.1365-2125.1985.tb05050.x.
Prednisolone pharmacokinetics and protein binding characteristics were studied in 10 renal transplant patients with various degrees of renal function (serum creatinine: 80-380 mumol/l) who received their usual oral maintenance dose of prednisolone (0.18 +/- 0.04 mg/kg). Plasma was assayed for prednisolone and hydrocortisone by h.p.l.c. and free prednisolone concentrations were determined in each sample by a rapid ultrafiltration technique. Free prednisolone area under curve (AUCu) ranged from 101 to 436 ng ml-1 h and was 6.3 to 15.0% of total prednisolone AUC. The fraction AUCu/AUC was closely related to serum albumin and creatinine concentrations determined at the time of study (multilinear regression correlation coefficient r2 = 0.830, P less than 0.0001); elevated serum creatinine and low albumin concentrations were associated with a higher % free. These results suggest that much of the variability in prednisolone protein binding could be attributed to inter-patient variability in serum albumin and creatinine concentrations. Total prednisolone concentrations would be potentially misleading in any comparisons made between patient groups with different renal function.
对10名肾功能程度各异(血清肌酐:80 - 380μmol/l)的肾移植患者进行了泼尼松龙的药代动力学和蛋白结合特性研究,这些患者接受了常规口服维持剂量的泼尼松龙(0.18±0.04mg/kg)。通过高效液相色谱法测定血浆中的泼尼松龙和氢化可的松,并采用快速超滤技术测定每个样本中的游离泼尼松龙浓度。游离泼尼松龙曲线下面积(AUCu)范围为101至436ng/ml·h,占泼尼松龙总AUC的6.3%至15.0%。AUCu/AUC分数与研究时测定的血清白蛋白和肌酐浓度密切相关(多元线性回归相关系数r2 = 0.830,P<0.0001);血清肌酐升高和白蛋白浓度降低与更高的游离百分比相关。这些结果表明,泼尼松龙蛋白结合的大部分变异性可能归因于患者间血清白蛋白和肌酐浓度的变异性。在对不同肾功能的患者组进行任何比较时,总泼尼松龙浓度可能会产生误导。